Universal Health Services (UHS)
(Real Time Quote from BATS)
$168.02 USD
+1.96 (1.18%)
Updated Apr 29, 2024 03:17 PM ET
1-Strong Buy of 5 1
A Value B Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
UHS 168.02 +1.96(1.18%)
Will UHS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for UHS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for UHS
3 Reasons Growth Investors Will Love Universal Health Services (UHS)
Sustained Product Demand Likely to Aid BD's (BDX) Q2 Earnings
UHS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Encompass Health (EHC) Stock Down Despite Q1 Earnings Beat
New Strong Buy Stocks for April 29th
Best Growth Stocks to Buy for April 29th
Other News for UHS
Strong Start and Upward Trends Prompt Buy Rating for Universal Health Services, Inc.
Universal Health price target raised by $8 at Barclays, here's why
Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Laboratory (LH) and Bristol-Myers Squibb (BMY)
Barclays Remains a Hold on Universal Health (UHS)
Universal Health’s Strong Q1 Performance and Upbeat Financial Outlook Justify Buy Rating